Lapses In Drug Quality - Marketers Will Also Be Accountable In India
Executive Summary
New proposed rules in India require the marketer of a drug to share responsibility for its quality along with the manufacturer.
You may also be interested in...
Indian Marketers Co-Accountable For Quality Lapses
New rules in India specify that a marketer of a drug will share the onus for quality and compliance along with the manufacturer. Enhanced punishment for misleading advertisements for a range of illnesses is also proposed, while calls for a statute to regulate pharma's marketing practices grow louder.
India Regulatory Diary: Marketers Co-Accountable For Lapses In Manufacturing Quality
New rules in India specify that a marketer of a drug will share the onus for quality and compliance along with the manufacturer. Enhanced punishment for misleading advertisements for a range of illnesses is also proposed, while calls for a statute to regulate pharma's marketing practices grow louder.
Third Party Manufacturer Lapses – Marketers Will Need To Share Onus In India
Drug marketers who don’t own-manufacture products in India may no longer be able to shrug off responsibility in the event of quality lapses at their third-party manufacturers.